STRATEGIC ANALYSIS OF THE WORLD PHARMACEUTICAL INDUSTRY Dragan Kesič∗ Received: 28. 2. 2007 Case study Accepted: 9. 7. 2008 UDC 65.01:615 The world pharmaceutical industry has been changing profoundly in the last decade. Intensive globalization‚ increased competitiveness and the fight for global market shares create new challenges for pharmaceutical companies. Fast globalization definitively reinforces the consolidation of the world pharmaceutical industry. Alliancing in forms of mergers and
Premium Pharmaceutical industry Generic drug Marketing
EXECUTIVE SUMMARY Global Pharma Industry is likely to grow at a CAGR of 5% to US $ 1 Trillion by 2013 The Pharmaceuticals Industry in India is the world’s 3 largest in terms of volume and stands 14th in terms of sale. Domestic pharma sector benefitted from increased thrust on Rural Health through bigger budgetary allocations in the Budget of 2009-10 According to PWC in 2010‚ India joined the league of Top 10 global pharmaceutical markets in terms of sales by 2020 with value reaching
Premium Pharmaceutical industry Generic drug
Organizational Structure in the Pharmaceuticals Industry Abstract Pfizer and Johnson & Johnson are the largest and most successful pharmaceutical companies in the world today. Each company has a massive workforce and conducts business in countries all over the globe. Both companies have used a high degree of horizontal differentiation in order to manage their business units more effectively. Operating companies are grouped together by their function‚ as well as the type of product the
Premium Management Fortune 500 Globalization
includes an external environmental analysis of Brazil’s pharmaceutical industry. The current pharmaceutical industry is still in its developing stage because the majority of pharmacological therapies made available to the public are either free or heavily subsidized by the government. The industry is also affected by a number of new regulations such as the National Drug Control System and Registration requirements for Active Pharmaceutical Ingredients (APIs) in November 2009‚ and new labelling &
Premium Pharmacology Medicine Economics
Research question/Purpose The Car Industry is changing its structure quickly. While Toyota earned some 124 billion SEK last year‚ GM lost about 65 billion SEK. Many mergers have happened and more changes are bound to happen. Write an essay pointing out the PEST-factors you find having a strong impact and causing these changes in the car industry. Also‚ reflect on the changes you think will happen in the years to come. 1.Introduction [1] PEST analysis is a process of checking and analyzing information
Premium Automotive industry Renault Automobile
PHARMACEUTICAL INDUSTRY ANALYSIS Industry Background: The total industry can broadly be classified into two categories. These are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production. Generic
Premium Pharmaceutical industry Pharmacology
for the industry going forward? 1.Though the average level of profitability in the pharmaceutical industry has been declining over time (In 2002‚ the average ROIC in the industry was 21.6%; by 2006‚ it had fallen to 14.5%)‚ historically‚ the pharmaceutical industry has been a profitable one. Because- Name of industry | Average ROIC(Between 2002 and 2006) | Pharmaceuticals | 16.45%(large) | computer hardware | 12.76% | Electronics | 3.88% | 2. The prospect for the industry for going
Premium Pharmaceutical industry Pharmacology Generic drug
Presentation on: Pfizer and the Pharmaceutical Industry Fletcher Leung Analyst Investment Analysis Group February 15‚ 2002 Presentation Agenda • Industry Overview: Research Based Pharmaceuticals • Pfizer – Company Specifics – Performance – Growth Drivers • Valuation – Comparables Analysis – DCF • Recommendation February 15‚ 2002 Page 2 Investment Analysis Group 1 Industry Overview Economic •Cost Effective Demographic Sociocultural •Aging Population
Premium
A Look at Data Mining in the Pharmaceutical Industry Topics Covered: 1) What is Data Mining and why is it used? 2) How is Data Mining used in the Pharmaceutical Industry? 3) Recent debate in the legality of Data Mining and the Pharmaceutical Industry Pharmaceutical companies are taking advantage of the growing use of technology in the healthcare arena by using data to enhance their marketing efforts and increase the quality of research and development. The process of data mining
Premium Data mining Pharmaceutical industry Pharmacology
PEST ANALYSIS A PEST (Political‚ Economic‚ Social and Technological) analysis is a major part of the environmental scanning section of strategic management and it is used by companies during market research and strategic analysis. Using a PEST analysis helps a business to understand various macro environmental factors that they need to take into consideration when determining the decline or growth of a particular market. What does
Premium Inflation Economics Technology